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Clinical PerspectiveWhat Is New?We systematically described the sex differences in long‐term mortality after major cardiac surgery in a large, real‐world cohort.We observed a statistically significant association between female sex and long‐term mortality after adjustment for key risk factors.Women experienced higher rates of mortality than men after coronary artery bypass grafting and combined coronary artery bypass grafting/mitral valve surgery, and mortality risk factors differed by sex.What Are the Clinical Implications?Perioperative optimization and long‐term follow‐up should be tailored to women with a history of recent myocardial infarction and diabetes mellitus and men with a history of chronic obstructive pulmonary disease and depression.Given the substantial sex differences in patient presentation for coronary and valvular heart disease, further efforts need to be directed at the education of both physicians and patients in the early recognition of acute presentation of cardiac disease in women.Given the poorer performance of standard risk scores in women, further research is needed to derive and validate sex‐specific risk prediction models in patients undergoing cardiac surgery.

Introduction {#jah34392-sec-0008}
============

Globally, 2 million cardiac surgery procedures are being performed each year.[1](#jah34392-bib-0001){ref-type="ref"} Steady improvements in postoperative survival can be largely attributed to important advancements in surgical technique, perioperative risk stratification, and care.[2](#jah34392-bib-0002){ref-type="ref"}, [3](#jah34392-bib-0003){ref-type="ref"}, [4](#jah34392-bib-0004){ref-type="ref"} Despite the well‐established role of patient sex on disease presentation, comorbid conditions, and the development of postoperative complications,[5](#jah34392-bib-0005){ref-type="ref"}, [6](#jah34392-bib-0006){ref-type="ref"}, [7](#jah34392-bib-0007){ref-type="ref"} little attention has been paid to the importance of sex in the prognosis of patients undergoing cardiac surgery.[6](#jah34392-bib-0006){ref-type="ref"}, [8](#jah34392-bib-0008){ref-type="ref"} To date, most reports of sex differences in cardiac surgery outcomes have been focused on short‐term survival.[9](#jah34392-bib-0009){ref-type="ref"}, [10](#jah34392-bib-0010){ref-type="ref"}, [11](#jah34392-bib-0011){ref-type="ref"}, [12](#jah34392-bib-0012){ref-type="ref"}, [13](#jah34392-bib-0013){ref-type="ref"}, [14](#jah34392-bib-0014){ref-type="ref"} Existing sex‐stratified analyses of long‐term outcomes are dated, single center in nature, and/or limited to isolated coronary artery bypass grafting (CABG) or a single type of procedure.[15](#jah34392-bib-0015){ref-type="ref"}, [16](#jah34392-bib-0016){ref-type="ref"}, [17](#jah34392-bib-0017){ref-type="ref"}, [18](#jah34392-bib-0018){ref-type="ref"} A current and comprehensive understanding of sex‐specific long‐term prognosis is needed to better inform operative decisions and provide tailored follow‐up strategies in cardiac surgery patients.[3](#jah34392-bib-0003){ref-type="ref"}, [19](#jah34392-bib-0019){ref-type="ref"} We, therefore, examined the sex differences in long‐term survival of all patients who underwent CABG, valve, or combined CABG/valve procedures in Ontario, Canada, between 2008 and 2016.

Methods {#jah34392-sec-0009}
=======

A flow chart detailing the process used to select the study cohort is shown in Figure [1](#jah34392-fig-0001){ref-type="fig"}.

![Cohort selection flow chart. CABG indicates coronary artery bypass grafting.](JAH3-8-e013260-g001){#jah34392-fig-0001}

Design and Study Population {#jah34392-sec-0010}
---------------------------

We conducted a population‐based, retrospective cohort study in Ontario, Canada. The Research Ethics Board of Sunnybrook Health Sciences Centre (Toronto, Canada) approved this study and waived the need for individual patient consent. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.

Included were adult Ontario residents, aged ≥40 years, who underwent CABG and/or aortic, mitral, or tricuspid valve surgery between October 1, 2008, and December 31, 2016. For those patients who underwent multiple cardiac procedures during the study period, the first procedure was considered the index procedure. Exclusion criteria were non‐Ontario residents, those with missing information on age and sex, and those who had concomitant arrhythmia, pulmonic valve, or thoracic aorta surgery. Ontario is Canada\'s most populous province, with a publicly funded, universal healthcare system that reimburses all covered services and providers.

Data Sources {#jah34392-sec-0011}
------------

We used the clinical registry data from CorHealth Ontario (<https://www.corhealthontario.ca>) and population‐level administrative healthcare databases with information on all Ontario residents, available at the Institute for Clinical Evaluative Sciences. Individuals who underwent specified cardiac procedures were identified from the CorHealth Ontario registry. CorHealth Ontario maintains a detailed prospective registry of all patients who undergo invasive cardiac procedures in Ontario. All 20 advanced cardiac hospitals in Ontario participate in the registry. It captures demographic, comorbidity, and procedural‐related information and has been validated through selected chart audits. In addition, CorHealth Ontario ejection fraction (EF) and angiographic data undergo core laboratory validation.[20](#jah34392-bib-0020){ref-type="ref"}

Administrative databases were linked deterministically by using encrypted unique confidential codes that preserve patient confidentiality. We linked the CorHealth Ontario registry (date and type of cardiac procedures, physiologic and comorbidity data) with the Canadian Institute for Health Information\'s Discharge Abstract Database (comorbidities and hospital admissions) and Same Day Surgery database (comorbidities), Ontario Health Insurance Plan database (physician service claims), Registered Persons Database (ascertainment of vital statistics), and Canadian census. These administrative databases have been validated for many outcomes, exposures, and comorbidities, including heart failure (HF), chronic obstructive pulmonary disease (COPD), asthma, hypertension, myocardial infarction (MI), and diabetes mellitus.[21](#jah34392-bib-0021){ref-type="ref"}, [22](#jah34392-bib-0022){ref-type="ref"}, [23](#jah34392-bib-0023){ref-type="ref"}, [24](#jah34392-bib-0024){ref-type="ref"}

Comorbidities {#jah34392-sec-0012}
-------------

Comorbidities were identified from the CorHealth Ontario registry and supplemented with data from the Discharge Abstract Database, Same Day Surgery database, and Ontario Health Insurance Plan database using *International Classification of Diseases, Tenth Revision* (*ICD‐10‐CA*), codes[25](#jah34392-bib-0025){ref-type="ref"} within 5 years before the index procedure, according to validated algorithms.[21](#jah34392-bib-0021){ref-type="ref"}, [23](#jah34392-bib-0023){ref-type="ref"}, [26](#jah34392-bib-0026){ref-type="ref"}, [27](#jah34392-bib-0027){ref-type="ref"} We estimated socioeconomic status based on patients' neighborhood median income in the Canadian census and determined their residence (rural versus urban) using the definitions from Statistics Canada.[28](#jah34392-bib-0028){ref-type="ref"} Procedural urgency was ascertained from the CorHealth Ontario registry. Height, weight, and body mass index were identified from the CorHealth Ontario registry; and they were used to define morbid obesity (weight \>159 kg or body mass index ≥40 kg/m^2^).[6](#jah34392-bib-0006){ref-type="ref"}, [7](#jah34392-bib-0007){ref-type="ref"}, [29](#jah34392-bib-0029){ref-type="ref"} Frailty status was identified using the Johns Hopkins Adjusted Clinical Groups frailty‐defining diagnoses indicator, which is an instrument designed and validated for research of frailty‐related outcomes and resource use using administrative data.[29](#jah34392-bib-0029){ref-type="ref"}, [30](#jah34392-bib-0030){ref-type="ref"}, [31](#jah34392-bib-0031){ref-type="ref"}, [32](#jah34392-bib-0032){ref-type="ref"}, [33](#jah34392-bib-0033){ref-type="ref"}, [34](#jah34392-bib-0034){ref-type="ref"}

Outcomes {#jah34392-sec-0013}
--------

The primary outcome was all‐cause mortality. We confirmed in‐hospital mortality using the Discharge Abstract Database and postdischarge mortality using the Registered Persons Database.

Statistical Analysis {#jah34392-sec-0014}
--------------------

A.B.E. and L.Y.S. had full access to all the data in the study and take responsibility for their integrity and for the data analysis. All analyses were performed in the overall cohort and then stratified by sex. Continuous variables are expressed as mean (SD), and categorical variables are expressed as number (proportion). Outcomes were assessed through December 31, 2017. Patients were censored at the front end if they lost possession of a valid Ontario health insurance card for 2 consecutive eligibility quarters (ie, assumed to have left the province of Ontario). Event time was defined as the date of index surgery until the date of the event or the date of the last follow‐up, whichever occurred earlier. Mortality rates in each group were calculated by using the Kaplan‐Meier method, and differences in mortality between groups were assessed with the log‐rank test. The proportionality assumption was tested by using log‐log plots for sex and type of surgery. Sex‐specific mortality rates were standardized by age, using the 2012 Canadian population as the reference.

The risk of death was assessed using a multivariable Cox proportional hazard model with adjustment for all variables listed in Table [1](#jah34392-tbl-0001){ref-type="table"}. We explored the modifying effect of sex by using multiplicative interaction terms. For the covariates that had a significant interaction effect with sex, we reported sex‐stratified hazard ratios (HRs) for the covariate, as well as HRs for female sex, stratified by the presence or absence of that covariate.

###### 

Baseline Characteristics, Stratified by Sex

  Variable                                                     Overall Population   No. (%) of Patients[a](#jah34392-note-0003){ref-type="fn"}   *P* Value       
  ------------------------------------------------------------ -------------------- ------------------------------------------------------------ --------------- ---------
  Surgery type                                                                                                                                                   
  Isolated CABG                                                52 546 (72.2)        10 743 (60.1)                                                41 803 (76.1)   \<0.001
  CABG+single valve[b](#jah34392-note-0004){ref-type="fn"}     7936 (10.9)          2098 (11.7)                                                  5838 (10.6)     
  CABG+multiple valve[c](#jah34392-note-0005){ref-type="fn"}   665 (0.9)            202 (1.1)                                                    463 (0.8)       
  Single valve[b](#jah34392-note-0004){ref-type="fn"}          10 368 (14.2)        4212 (23.6)                                                  6156 (11.2)     
  Multiple valve[c](#jah34392-note-0005){ref-type="fn"}        1309 (1.8)           619 (3.5)                                                    690 (1.3)       
  Age, mean±SD, y                                              67.0±10.2            69.1±10.1                                                    66.2±10.1       \<0.001
  40--64                                                       28 941 (39.7)        5601 (31.3)                                                  23 340 (42.5)   \<0.001
  65--74                                                       25 229 (34.6)        6206 (34.7)                                                  19 023 (34.6)   
  75--84                                                       16 806 (23.1)        5363 (30.0)                                                  11 443 (20.8)   
  ≥85                                                          1848 (2.5)           704 (3.9)                                                    1144 (2.1)      
  Rural residence                                              11 763 (16.2)        2805 (15.7)                                                  8958 (16.3)     
  Income quintile                                                                                                                                                
  1 (Lowest)                                                   13 448 (18.5)        3831 (21.4)                                                  9617 (17.5)     \<0.001
  2                                                            14 696 (20.2)        3762 (21.0)                                                  10 934 (19.9)   
  3                                                            14 759 (20.3)        3559 (19.9)                                                  11 200 (20.4)   
  4                                                            15 017 (20.6)        3478 (19.5)                                                  11 539 (21.0)   
  5 (Highest)                                                  14 532 (20.0)        3145 (17.6)                                                  11 387 (20.7)   
  Missing                                                      372 (0.5)            99 (0.6)                                                     273 (0.5)       
  Hypertension                                                 62 852 (86.3)        15 892 (88.9)                                                46 960 (85.5)   \<0.001
  Atrial fibrillation                                          5165 (7.1)           1621 (9.1)                                                   3544 (6.4)      \<0.001
  Recent MI                                                    22 952 (31.5)        5283 (29.6)                                                  17 669 (32.2)   \<0.001
  Remote MI                                                    11 605 (15.9)        2555 (14.3)                                                  9050 (16.5)     \<0.001
  Previous PCI                                                 10 532 (14.5)        2245 (12.6)                                                  8287 (15.1)     \<0.001
  Heart failure                                                19 847 (27.3)        6378 (35.7)                                                  13 469 (24.5)   \<0.001
  LVEF, %                                                                                                                                                        
  ≥50                                                          48 185 (66.2)        13 081 (73.2)                                                35 104 (63.9)   \<0.001
  35--50                                                       15 448 (21.2)        3010 (16.8)                                                  12 438 (22.6)   
  20--35                                                       6044 (8.3)           1123 (6.3)                                                   4921 (9.0)      
  \<20                                                         1113 (1.5)           165 (0.9)                                                    948 (1.7)       
  Missing                                                      2034 (2.8)           495 (2.8)                                                    1539 (2.8)      
  Cerebrovascular disease                                      7420 (10.2)          2012 (11.3)                                                  5408 (9.8)      \<0.001
  Peripheral arterial disease                                  9139 (12.5)          2314 (12.9)                                                  6825 (12.4)     0.065
  COPD or asthma                                               21 419 (29.4)        6232 (34.9)                                                  15 187 (27.6)   \<0.001
  Diabetes mellitus                                            32 812 (45.1)        8458 (47.3)                                                  24 354 (44.3)   \<0.001
  Morbid obesity                                               28 391 (39.0)        5449 (30.5)                                                  22 942 (41.8)   \<0.001
  Hypothyroidism                                               1419 (1.9)           786 (4.4)                                                    633 (1.2)       \<0.001
  Liver disease                                                633 (0.9)            161 (0.9)                                                    472 (0.9)       0.60
  Anemia                                                       7347 (10.1)          2564 (14.3)                                                  4783 (8.7)      \<0.001
  Venous thromboembolism                                       288 (0.4)            73 (0.4)                                                     215 (0.4)       0.99
  Dialysis                                                     1531 (2.1)           390 (2.2)                                                    1141 (2.1)      0.39
  Baseline creatinine, μmol/L                                                                                                                                    
  120--179                                                     6635 (9.1)           1219 (6.8)                                                   5416 (9.9)      \<0.001
  \<120                                                        60 190 (82.7)        15 258 (85.4)                                                44 932 (81.8)   
  ≥180                                                         2435 (3.3)           537 (3.0)                                                    1898 (3.5)      
  Missing                                                      3564 (4.9)           860 (4.8)                                                    2704 (4.9)      
  Chronic renal disease                                        3133 (4.3)           771 (4.3)                                                    2362 (4.3)      0.93
  Dementia                                                     176 (0.2)            55 (0.3)                                                     121 (0.2)       0.038
  Depression                                                   1089 (1.5)           417 (2.3)                                                    672 (1.2)       \<0.001
  Psychosis                                                    161 (0.2)            58 (0.3)                                                     103 (0.2)       0.001
  Primary tumor                                                3770 (5.2)           817 (4.6)                                                    2953 (5.4)      \<0.001
  Metastatic cancer                                            375 (0.5)            114 (0.6)                                                    261 (0.5)       0.008
  Charlson score, median (IQR)                                 1 (0--3)             2 (0--3)                                                     1 (0--3)        \<0.001
  Frailty[c](#jah34392-note-0005){ref-type="fn"}               11 685 (16.0)        3601 (20.1)                                                  8084 (14.7)     \<0.001

CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Unless otherwise stated.

Mitral, aortic, or tricuspid surgery.

According to the Johns Hopkins Adjusted Clinical Groups frailty‐defining diagnoses indicator.[29](#jah34392-bib-0029){ref-type="ref"}, [30](#jah34392-bib-0030){ref-type="ref"}, [31](#jah34392-bib-0031){ref-type="ref"}, [32](#jah34392-bib-0032){ref-type="ref"}, [33](#jah34392-bib-0033){ref-type="ref"}, [34](#jah34392-bib-0034){ref-type="ref"}

As women and men differed in baseline and operative characteristics, we conducted a sensitivity analysis by using inverse probability of treatment weighting using propensity scores to estimate the effect of sex. Specifically, we used logistic regression to estimate propensity scores of being women, using the same set of covariates as those used in the multivariable Cox proportional hazards model. We used a weighted Cox proportional hazards model to estimate the effect of sex on mortality in the sample weighted by inverse probability of treatment weighting. We then used a robust sandwich variance estimator to account for the within‐subject correlation in outcomes induced by weighting.

Analyses were performed using SAS 9.4 (SAS Institute, Cary, NC), with statistical significance defined by a 2‐sided *P\<*0.05.

Results {#jah34392-sec-0015}
=======

A total of 72 824 patients were included in the study (24% women). The baseline patient characteristics are summarized in Table [1](#jah34392-tbl-0001){ref-type="table"}. Compared with men, women were older, were more frail, had lower socioeconomic status, and were more likely to have preserved left ventricular EF and comorbid conditions, such as valvular heart disease, atrial fibrillation, hypertension, cerebrovascular and peripheral arterial disease, COPD, diabetes mellitus, hypothyroidism, and anemia. In contrast, women were less likely than men to have had an MI, to have had a previous percutaneous coronary intervention (PCI), to undergo isolated CABG, to be morbidly obese, or to abuse alcohol.

Figure [2](#jah34392-fig-0002){ref-type="fig"} demonstrates the relative frequencies of surgical procedures performed in women and men. Isolated CABG was the most common cardiac procedure, accounting for 72.2% of the provincial procedural volume. Although valvular procedures were performed in near equal frequencies in both sexes, most CABG and combined CABG/valve procedures were performed in men. Table [2](#jah34392-tbl-0002){ref-type="table"} summarizes baseline patient characteristics according to surgery type. Isolated CABG was most likely to be performed in younger men with a history of reduced left ventricular EF and previous MI and PCI; but least likely to be performed in those with HF. Compared with those who underwent combined CABG/valve procedures, those who underwent isolated valve surgery were younger and were more likely to have preserved left ventricular EF and a lower burden of comorbidities, as evidenced by a lower Charlson comorbidity index. Those who underwent combined CABG/multiple valve surgery were among the frailest and burdened with the highest number of comorbidities. The proportionality assumption was satisfied for age and type of surgery.

![Percentage of men and women who underwent each of the 5 cardiac procedure categories. CABG indicates coronary artery bypass grafting.](JAH3-8-e013260-g002){#jah34392-fig-0002}

###### 

Baseline Characteristics, Stratified by Type of Surgery

  Variable                                         Overall Population (N=72 824)   No. (%) of Patients[a](#jah34392-note-0007){ref-type="fn"}   *P* Value                                              
  ------------------------------------------------ ------------------------------- ------------------------------------------------------------ ------------- ------------ ------------- ------------- ---------
  Age, mean±SD, y                                  67.0±10.2                       65.9±9.8                                                     72.6±9.0      72.5±9.1     67.5±11.2     68.3±11.4     \<0.001
  40--64                                           28 941 (39.7)                   22 925 (43.6)                                                1460 (18.4)   129 (19.4)   3969 (38.3)   458 (35.0)    \<0.001
  65--74                                           25 229 (34.6)                   18 626 (35.4)                                                2795 (35.2)   216 (32.5)   3197 (30.8)   395 (30.2)    
  75--84                                           16 806 (23.1)                   10 220 (19.4)                                                3128 (39.4)   269 (40.5)   2801 (27.0)   388 (29.6)    
  ≥85                                              1848 (2.5)                      775 (1.5)                                                    553 (7.0)     51 (7.7)     401 (3.9)     68 (5.2)      
  Rural residence                                  11 763 (16.2)                   8204 (15.6)                                                  1457 (18.4)   143 (21.5)   1756 (16.9)   203 (15.5)    
  Income quintile                                                                                                                                                                                      
  1 (Lowest)                                       13 448 (18.5)                   10 003 (19.0)                                                1370 (17.3)   102 (15.3)   1728 (16.7)   245 (18.7)    \<0.001
  2                                                14 696 (20.2)                   10 724 (20.4)                                                1608 (20.3)   148 (22.3)   1959 (18.9)   257 (19.6)    
  3                                                14 759 (20.3)                   10 627 (20.2)                                                1609 (20.3)   157 (23.6)   2117 (20.4)   249 (19.0)    
  4                                                15 017 (20.6)                   10 714 (20.4)                                                1705 (21.5)   127 (19.1)   2214 (21.4)   257 (19.6)    
  5 (Highest)                                      14 532 (20.0)                   10 184 (19.4)                                                1617 (20.4)   129 (19.4)   2310 (22.3)   292 (22.3)    
  Missing                                          372 (0.5)                       294 (0.6)                                                    27 (0.3)      ≤5           40 (0.4)      9 (0.7)       
  Hypertension                                     62 852 (86.3)                   46 111 (87.8)                                                7185 (90.5)   595 (89.5)   7954 (76.7)   1007 (76.9)   \<0.001
  Atrial fibrillation                              5165 (7.1)                      2373 (4.5)                                                   990 (12.5)    155 (23.3)   1343 (13.0)   304 (23.2)    \<0.001
  Recent MI                                        22 952 (31.5)                   20 684 (39.4)                                                1659 (20.9)   132 (19.8)   422 (4.1)     55 (4.2)      \<0.001
  Remote MI                                        11 605 (15.9)                   9432 (17.9)                                                  1295 (16.3)   108 (16.2)   679 (6.5)     91 (7.0)      \<0.001
  Previous PCI                                     10 532 (14.5)                   8773 (16.7)                                                  1004 (12.7)   68 (10.2)    617 (6.0)     70 (5.3)      \<0.001
  Heart failure                                    19 847 (27.3)                   10 126 (19.3)                                                3714 (46.8)   430 (64.7)   4729 (45.6)   848 (64.8)    \<0.001
  LVEF, %                                                                                                                                                                                              
  ≥50                                              48 185 (66.2)                   32 237 (61.4)                                                5630 (70.9)   435 (65.4)   8843 (85.3)   1040 (79.4)   
  35--50                                           15 448 (21.2)                   12 762 (24.3)                                                1398 (17.6)   145 (21.8)   967 (9.3)     176 (13.4)    
  20--35                                           6044 (8.3)                      4911 (9.3)                                                   654 (8.2)     66 (9.9)     346 (3.3)     67 (5.1)      
  \<20                                             1113 (1.5)                      905 (1.7)                                                    139 (1.8)     13 (2.0)     43 (0.4)      13 (1.0)      
  Missing                                          2034 (2.8)                      1731 (3.3)                                                   115 (1.4)     6 (0.9)      169 (1.6)     13 (1.0)      \<0.001
  Cerebrovascular disease                          7420 (10.2)                     5132 (9.8)                                                   1073 (13.5)   82 (12.3)    970 (9.4)     163 (12.5)    \<0.001
  Peripheral arterial disease                      9139 (12.5)                     6424 (12.2)                                                  1389 (17.5)   108 (16.2)   1079 (10.4)   139 (10.6)    \<0.001
  COPD or asthma                                   21 419 (29.4)                   14 702 (28.0)                                                2726 (34.3)   251 (37.7)   3301 (31.8)   439 (33.5)    \<0.001
  Diabetes mellitus                                32 812 (45.1)                   25 267 (48.1)                                                3639 (45.9)   266 (40.0)   3218 (31.0)   422 (32.2)    \<0.001
  Morbid obesity                                   28 391 (39.0)                   20 490 (39.0)                                                3106 (39.1)   281 (42.3)   3951 (38.1)   563 (43.0)    0.004
  Hypothyroidism                                   1419 (1.9)                      969 (1.8)                                                    186 (2.3)     18 (2.7)     206 (2.0)     40 (3.1)      \<0.001
  Liver disease                                    633 (0.9)                       351 (0.7)                                                    81 (1.0)      11 (1.7)     153 (1.5)     37 (2.8)      \<0.001
  Anemia                                           7347 (10.1)                     4918 (9.4)                                                   1113 (14.0)   136 (20.5)   977 (9.4)     203 (15.5)    \<0.001
  Venous thromboembolism                           288 (0.4)                       173 (0.3)                                                    46 (0.6)      ≤5           57 (0.5)      10 (0.8)      \<0.001
  Dialysis                                         1531 (2.1)                      1047 (2.0)                                                   233 (2.9)     22 (3.3)     195 (1.9)     34 (2.6)      \<0.001
  Baseline creatinine, μmol/L                                                                                                                                                                          
  120--179                                         6635 (9.1)                      4487 (8.5)                                                   1037 (13.1)   93 (14.0)    855 (8.2)     163 (12.5)    \<0.001
  \<120                                            60 190 (82.7)                   43 934 (83.6)                                                6158 (77.6)   522 (78.5)   8538 (82.3)   1038 (79.3)   
  ≥180                                             2435 (3.3)                      1698 (3.2)                                                   381 (4.8)     32 (4.8)     261 (2.5)     63 (4.8)      
  Missing                                          3564 (4.9)                      2427 (4.6)                                                   360 (4.5)     18 (2.7)     714 (6.9)     45 (3.4)      
  Chronic renal disease                            3133 (4.3)                      2109 (4.0)                                                   516 (6.5)     43 (6.5)     399 (3.8)     66 (5.0)      \<0.001
  Dementia                                         176 (0.2)                       98 (0.2)                                                     41 (0.5)      6 (0.9)      27 (0.3)      ≤5            \<0.001
  Depression                                       1089 (1.5)                      733 (1.4)                                                    149 (1.9)     13 (2.0)     157 (1.5)     37 (2.8)      \<0.001
  Psychosis                                        161 (0.2)                       102 (0.2)                                                    17 (0.2)      ≤5           33 (0.3)      6 (0.5)       0.025
  Primary tumor                                    3770 (5.2)                      2486 (4.7)                                                   539 (6.8)     48 (7.2)     601 (5.8)     96 (7.3)      \<0.001
  Metastatic cancer                                375 (0.5)                       248 (0.5)                                                    40 (0.5)      ≤5           72 (0.7)      10 (0.8)      0.03
  Charlson score, median (IQR)                     1 (0--3)                        2 (0--3)                                                     2 (0--3)      2 (1--3)     1 (0--2)      1 (0--2)      \<0.001
  Frailty[c](#jah34392-note-0009){ref-type="fn"}   11 685 (16.0)                   8623 (16.4)                                                  1491 (18.8)   154 (23.2)   1204 (11.6)   213 (16.3)    \<0.001

CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Unless otherwise stated.

Mitral, aortic, or tricuspid valve surgery.

According to the Johns Hopkins Adjusted Clinical Groups frailty‐defining diagnoses indicator.[29](#jah34392-bib-0029){ref-type="ref"}, [30](#jah34392-bib-0030){ref-type="ref"}, [31](#jah34392-bib-0031){ref-type="ref"}, [32](#jah34392-bib-0032){ref-type="ref"}, [33](#jah34392-bib-0033){ref-type="ref"}, [34](#jah34392-bib-0034){ref-type="ref"}

Survival at 30 Days {#jah34392-sec-0016}
-------------------

Overall, women were more likely to die than men during the first 30 days after surgery (2.7% versus 1.6%; *P*\<0.001). Thirty‐day mortality rates after isolated CABG, CABG/single‐valve, CABG/multiple‐valve, single‐valve, and multiple‐valve surgery were 1.4%, 4.0%, 7.5%, 1.7%, and 5.2%, respectively (*P*\<0.001). The sex‐ and procedure‐stratified 30‐day crude and age‐standardized mortality rates (AMRs) are summarized in Table [3](#jah34392-tbl-0003){ref-type="table"}.

###### 

CMRs and AMRs Within 30 Days and in Long‐Term Follow‐Up After Surgery

  Surgery                                                      Sex     No. of Deaths   Person‐Years        CMR per 1000 Person‐Years (95% CI)   AMR per 1000 Person‐Years (95% CI)   *P* Value
  ------------------------------------------------------------ ------- --------------- ------------------- ------------------------------------ ------------------------------------ -----------
  30‐d Mortality                                                                                                                                                                     
  CABG                                                         Women   235             317 222             0.7 (0.7--0.8)                       0.6 (0.5--0.7)                       \<0.001
  Men                                                          506     1 244 223       0.4 (0.4--0.4)      0.4 (0.3--0.4)                                                            
  CABG+single valve[a](#jah34392-note-0011){ref-type="fn"}     Women   112             60 505              1.9 (1.5--2.2)                       1.6 (1.1--2.4)                       0.008
  Men                                                          207     171 205         1.2 (1.1--1.4)      0.9 (0.7--1.2)                                                            
  CABG+multiple valve[a](#jah34392-note-0011){ref-type="fn"}   Women   22              5588                3.9 (2.5--6.0)                       2.0 (0.9--3.9)                       0.95
  Men                                                          28      13 298          2.1 (1.4--3.0)      2.0 (0.9--3.7)                                                            
  Single valve[a](#jah34392-note-0011){ref-type="fn"}          Women   87              124 712             0.7 (0.6--0.9)                       0.6 (0.4--0.7)                       0.11
  Men                                                          90      183 088         0.5 (0.4--0.6)      0.4 (0.3--0.5)                                                            
  Multiple valve[a](#jah34392-note-0011){ref-type="fn"}        Women   30              17 971              1.7 (1.13--2.38)                     1.2 (0.7--2.0)                       0.17
  Men                                                          38      19 951          1.9 (1.35--2.61)    1.9 (1.2--2.7)                                                            
  Long‐term mortality                                                                                                                                                                
  CABG                                                         Women   1749            49 723              35.2 (33.6--36.9)                    28.4 (26.7--30.1)                    \<0.001
  Men                                                          5219    196 646         26.5 (25.8--27.3)   23.6 (22.8--24.5)                                                         
  CABG+single valve[a](#jah34392-note-0011){ref-type="fn"}     Women   647             8869                73.0 (67.4--78.8)                    58.2 (49.7--67.6)                    0.01
  Men                                                          1567    24 420          64.2 (61.0--67.4)   46.5 (42.9--50.3)                                                         
  CABG+multiple valve[a](#jah34392-note-0011){ref-type="fn"}   Women   79              687                 115.0 (91.1--143.4)                  75.2 (51.4--106.2)                   0.59
  Men                                                          149     1758            84.8 (71.7--99.5)   66.6 (49.5--87.7)                                                         
  Single valve                                                 Women   802             18 803              42.7 (39.8--45.7)                    29.7 (27.0--32.6)                    0.64
  Men                                                          1055    27 352          38.6 (36.3--41.0)   30.5 (28.4--32.7)                                                         
  Multiple valve                                               Women   126             2253                55.9 (46.6--66.6)                    41.7 (32.0--53.3)                    0.11
  Men                                                          165     2685            61.5 (52.4--71.6)   53.7 (44.3--64.4)                                                         

AMR indicates age‐standardized mortality rate; CABG, coronary artery bypass grafting; CMR, crude mortality rate.

Mitral, aortic, or tricuspid valve surgery.

Sex Differences in Long‐Term Survival {#jah34392-sec-0017}
-------------------------------------

The median follow‐up period was 5 years (interquartile range, 3--7 years), and the maximum follow‐up period was 9 years. Women were more likely than men to die within 1 year after a cardiac procedure (6.2% versus 4.1%; *P*\<0.001) and during long‐term follow‐up (19.0% versus 14.8%; *P*\<0.001). The multivariable adjusted long‐term survival curves for women and men are illustrated in Figure [3](#jah34392-fig-0003){ref-type="fig"}.

![Adjusted Kaplan‐Meier curves of long‐term survival in women and men.](JAH3-8-e013260-g003){#jah34392-fig-0003}

Sex modified the correlation between mortality and type of surgery, age, recent and remote MI, previous PCI, COPD/asthma, and depression. The HRs for sex, stratified by the presence or absence of these characteristics, are presented in Table [4](#jah34392-tbl-0004){ref-type="table"}; the sex‐stratified HRs for the same characteristics are presented in Table [5](#jah34392-tbl-0005){ref-type="table"}. Taken together, women who underwent surgery involving CABG had a higher risk of death than men (Table [4](#jah34392-tbl-0004){ref-type="table"}); and this observation was especially evident in women who underwent CABG/multiple valve reconstruction (Table [5](#jah34392-tbl-0005){ref-type="table"}). Although female sex accentuated the risk of long‐term mortality in patients aged \<75 years (Table [4](#jah34392-tbl-0004){ref-type="table"}), the association between sex and long‐term mortality was more accentuated in men aged \>75 years compared with women of the same age group (Table [5](#jah34392-tbl-0005){ref-type="table"}). In addition, although remote MI, recent MI, and previous PCI were associated with higher risks of death in women (Table [4](#jah34392-tbl-0004){ref-type="table"}), previous PCI was associated with a lower risk of death in men and not in women (Table [5](#jah34392-tbl-0005){ref-type="table"}). Both COPD/asthma and depression were associated with a slightly higher risk of death in men compared with women (Table [5](#jah34392-tbl-0005){ref-type="table"}).

###### 

Impact of Female Sex, Stratified by the Presence and Absence of Characteristics That Have a Significant Interaction Effect With Sex

  Characteristics                                               Adjusted HR for Women (95% CI)   Interaction *P* Value   
  ------------------------------------------------------------- -------------------------------- ----------------------- ---------
  Surgery                                                                                                                
  CABG                                                          1.15 (1.08--1.21)                ...                     0.03
  CABG+single valve[a](#jah34392-note-0014){ref-type="fn"}      1.11 (1.01--1.22)                ...                     
  CABG+multiple valves[a](#jah34392-note-0014){ref-type="fn"}   1.34 (1.02--1.77)                ...                     
  Single valve[a](#jah34392-note-0014){ref-type="fn"}           1.06 (0.96--1.16)                ...                     
  Multiple valves[a](#jah34392-note-0014){ref-type="fn"}        0.82 (0.65--1.04)                ...                     
  Age group, y                                                                                                           
  40--64                                                        1.22 (1.11--1.34)                ...                     0.001
  65--74                                                        1.20 (1.11--1.29)                ...                     
  75--84                                                        1.04 (0.97--1.10)                ...                     
  ≥85                                                           0.97 (0.84--1.13)                ...                     
  Recent MI                                                     1.27 (1.19--1.36)                1.03 (0.98--1.09)       \<0.001
  Remote MI                                                     1.21 (1.11--1.32)                1.09 (1.04--1.14)       0.03
  Previous PCI                                                  1.24 (1.11--1.39)                1.10 (1.05--1.15)       0.04
  COPD/asthma                                                   1.06 (1.00--1.13)                1.16 (1.09--1.22)       0.05
  Depression                                                    0.88 (0.71--1.11)                1.12 (1.07--1.17)       0.04

CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Mitral, aortic, or tricuspid valve surgery.

###### 

Sex‐Specific Risk Factors of Long‐Term Mortality

  Characteristics                                               Adjusted HR (95% CI)   Interaction *P* Value   
  ------------------------------------------------------------- ---------------------- ----------------------- ---------
  Surgery                                                                                                      
  CABG                                                          Reference              Reference               0.03
  CABG+single valve[a](#jah34392-note-0016){ref-type="fn"}      1.39 (1.27--1.53)      1.43 (1.35--1.53)       
  CABG+multiple valves[a](#jah34392-note-0016){ref-type="fn"}   1.92 (1.53--2.42)      1.64 (1.39--1.94)       
  Single valve[a](#jah34392-note-0016){ref-type="fn"}           1.23 (1.12--1.35)      1.34 (1.24--1.44)       
  Multiple valves[a](#jah34392-note-0016){ref-type="fn"}        1.24 (1.03--1.49)      1.73 (1.47--2.03)       
  Age group, y                                                                                                 
  40--64                                                        Reference              Reference               0.001
  65--74                                                        1.71 (1.54--1.89)      1.74 (1.64--1.85)       
  75--84                                                        2.78 (2.52--3.07)      3.28 (3.09--3.49)       
  ≥85                                                           4.24 (3.66--4.91)      5.31 (4.79--5.9)        
  Recent MI                                                     1.30 (1.21--1.40)      1.05 (1.00--1.11)       \<0.001
  Remote MI                                                     1.27 (1.17--1.38)      1.14 (1.08--1.20)       0.03
  Previous PCI                                                  1.06 (0.96--1.17)      0.93 (0.87--0.99)       0.04
  COPD/asthma                                                   1.26 (1.18--1.35)      1.37 (1.31--1.43)       0.05
  Depression                                                    1.20 (1.00--1.44)      1.52 (1.32--1.75)       0.04

CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Mitral, aortic, or tricuspid valve surgery.

In the sensitivity analysis in which we used inverse probability of treatment weighting of the propensity score, we found female sex to be associated with a higher risk of death (HR, 1.10; 95% CI, 1.05--1.16).

Long‐Term Survival by Surgery Type {#jah34392-sec-0018}
----------------------------------

The sex‐ and procedure‐specific mortality rates are shown in Table [5](#jah34392-tbl-0005){ref-type="table"}. Overall, long‐term AMRs were lowest in patients who underwent isolated CABG, followed by single‐valve, multiple‐valve, CABG/single‐valve, and CABG/multiple‐valve surgeries. AMRs after isolated CABG and combined CABG/single‐valve procedures were significantly higher in women than men. After CABG/multiple‐valve surgeries, women had numerically higher AMR than men, whereas after multiple‐valve surgery, men had numerically higher AMR than women. There were no sex‐based differences in long‐term survival after single‐valve surgery. The adjusted Kaplan‐Meier survival curves (Figure [4](#jah34392-fig-0004){ref-type="fig"}) also support these findings.

![Adjusted survival curves in patients who underwent isolated valvular procedures (**left**) and those who underwent procedures involving coronary revascularization (**right**). CABG indicates coronary artery bypass grafting.](JAH3-8-e013260-g004){#jah34392-fig-0004}

As long‐term survival differed by surgery type, we also determined the valve‐specific mortality rates and HRs for the most commonly performed surgical procedures (ie, aortic valve, mitral valve, CABG/aortic valve, CABG/mitral valve, and combined mitral/aortic valve) (Figure [S1](#jah34392-sup-0001){ref-type="supplementary-material"}). We found that women had higher AMRs compared with men after isolated CABG (*P*\<0.001) and combined CABG/mitral valve procedures (*P*=0.005). There were no statistically significant differences in long‐term survival between sexes after procedures other than isolated CABG and combined CABG/mitral valve surgery.

We then examined those who had isolated mitral or aortic valve procedures for any sex‐specific differences in outcomes. Specifically, we compared the long‐term mortality of women versus men, who underwent the following: (1) mitral valve repair versus replacement (Figure [5](#jah34392-fig-0005){ref-type="fig"}) and (2) simple (ie, isolated) aortic valve replacement (AVR) versus complex AVR (ie, involving root reconstruction and/or coronary reimplantation) (Figure [6](#jah34392-fig-0006){ref-type="fig"}). In patients who underwent isolated mitral valve surgery, those who underwent repair had higher rates of long‐term survival compared with those who had replacement surgery. In addition, in patients who had mitral valve repair, men had higher rates of long‐term survival than women. Conversely, in those who had mitral valve replacement (MVR), women had higher rates of long‐term survival than men. In patients who underwent isolated AVR, there were no statistically significant differences in long‐term survival when comparing simple with complex procedure and women with men.

![Kaplan‐Meier survival curves in women and men who underwent mitral valve repair vs replacement.](JAH3-8-e013260-g005){#jah34392-fig-0005}

![Kaplan‐Meier survival curves of women and men who underwent simple vs complex aortic valve replacement.](JAH3-8-e013260-g006){#jah34392-fig-0006}

We conducted a post hoc analysis to determine whether there were sex differences in the type of surgery performed during an acute, nonelective cardiac admission (Table [S1](#jah34392-sup-0001){ref-type="supplementary-material"}). We found that women were more likely than men to have isolated CABG during an acute cardiac admission. There were no sex differences in other urgent procedures performed.

Discussion {#jah34392-sec-0019}
==========

In this population‐based study, we found patient sex to be an important determinant of long‐term survival after cardiac surgery. Three main findings were derived from this study. (1) Long‐term AMR was lowest in patients who underwent isolated CABG and highest among those who underwent combined CABG/multiple valve surgery. (2) Women had significantly higher AMRs than men after CABG and combined CABG/mitral valve surgery. Overall, AMR was numerically higher in women than men after any procedure involving coronary revascularization. (3) Men had higher rates of long‐term survival than women after isolated mitral valve repair, whereas women had higher rates of long‐term survival than men after isolated MVR.

Sex Differences in Long‐Term Survival After Cardiac Surgery {#jah34392-sec-0020}
-----------------------------------------------------------

It is well documented that compared with men, women who present for CABG are older, have a smaller body surface area, are more likely to require an urgent/emergent operation, and have a greater burden of comorbid conditions, such as diabetes mellitus, hypertension, HF, cerebrovascular disease, and anemia.[6](#jah34392-bib-0006){ref-type="ref"}, [11](#jah34392-bib-0011){ref-type="ref"}, [12](#jah34392-bib-0012){ref-type="ref"}, [35](#jah34392-bib-0035){ref-type="ref"}, [36](#jah34392-bib-0036){ref-type="ref"}, [37](#jah34392-bib-0037){ref-type="ref"} Similar sex differences in comorbidities have been noted in patients presenting for isolated mitral,[17](#jah34392-bib-0017){ref-type="ref"}, [38](#jah34392-bib-0038){ref-type="ref"}, [39](#jah34392-bib-0039){ref-type="ref"} aortic valve,[15](#jah34392-bib-0015){ref-type="ref"} and concomitant CABG and valve surgeries.[40](#jah34392-bib-0040){ref-type="ref"} Our results corroborate these findings in that women presenting for cardiac surgery were older, more frail, and more medically complex than men. In addition, women with cardiovascular diseases often experience a delay in diagnosis and treatment when compared with men, which may, in part, explain the more advanced coronary or valvular pathological conditions observed in women at the time of surgery.[6](#jah34392-bib-0006){ref-type="ref"}, [41](#jah34392-bib-0041){ref-type="ref"}, [42](#jah34392-bib-0042){ref-type="ref"} These established sex differences explain our overall observation of lower estimated long‐term survival in women after cardiac surgery, and of female sex being an independent risk factor for long‐term mortality.

The Impact of Procedure Type on Survival {#jah34392-sec-0021}
----------------------------------------

We found that valvular procedures were performed in near equal frequencies in both sexes, whereas procedures involving coronary revascularization were performed much more frequently in men. These findings are consistent with the literature.[6](#jah34392-bib-0006){ref-type="ref"}, [43](#jah34392-bib-0043){ref-type="ref"}, [44](#jah34392-bib-0044){ref-type="ref"} Female sex has been reported as an independent risk factor for perioperative mortality as well as mortality within 5 years of CABG.[6](#jah34392-bib-0006){ref-type="ref"}, [7](#jah34392-bib-0007){ref-type="ref"}, [35](#jah34392-bib-0035){ref-type="ref"}, [45](#jah34392-bib-0045){ref-type="ref"}, [46](#jah34392-bib-0046){ref-type="ref"} However, sex does not consistently influence survival after 5 years.[9](#jah34392-bib-0009){ref-type="ref"}, [14](#jah34392-bib-0014){ref-type="ref"}, [40](#jah34392-bib-0040){ref-type="ref"}, [47](#jah34392-bib-0047){ref-type="ref"}, [48](#jah34392-bib-0048){ref-type="ref"} Nicolini et al,[48](#jah34392-bib-0048){ref-type="ref"} in a study of 1332 women and 5976 men who underwent isolated CABG in Italy between 2003 and 2013, found no sex difference in survival at mean follow‐up of 8 years. In a study of 607 women and 3326 men who underwent isolated CABG in Stockholm, Sweden, between 1980 and 1989, significant sex differences in survival were observed at 30 days but not in long‐term (5‐year) follow‐up.[49](#jah34392-bib-0049){ref-type="ref"} This study compared 5‐year mortality in women and men who survived the index surgical admission, thus removing the contribution of early female mortality to the calculation of long‐term risk. In addition, this study has a small sample size, especially in the female group; and temporal changes in surgical outcomes, as well as geographic differences in surgical practice and health‐seeking behavior, may in part explain these differences in results. A recent meta‐analysis[45](#jah34392-bib-0045){ref-type="ref"} showed that female sex was an independent risk factor for mortality at 5 years after isolated CABG (random‐effects odds ratio, 1.14; 95% CI (confidence interval), 1.08--1.20; I^2^=0%). This observation is in keeping with the current study, in which we found the HR associated with female sex to be 1.10 (95% CI, 1.05--1.16) after inverse probability of treatment weighting using the propensity score. In addition, poorer survival after CABG in women may be attributed to smaller coronary size,[50](#jah34392-bib-0050){ref-type="ref"} which may contribute to technical challenges,[12](#jah34392-bib-0012){ref-type="ref"}, [51](#jah34392-bib-0051){ref-type="ref"} the risk of graft‐coronary mismatch, and incomplete revascularization.[52](#jah34392-bib-0052){ref-type="ref"}, [53](#jah34392-bib-0053){ref-type="ref"} The diagnosis of coronary artery disease may be delayed in women compared with men, possibly because of the likelihood for an atypical presentation to coronary artery disease for women.[54](#jah34392-bib-0054){ref-type="ref"} Women are also older, have a higher burden of comorbidities, are more likely to have been hospitalized for HF within 90 days and 1 year before CABG,[6](#jah34392-bib-0006){ref-type="ref"} and have higher rates of postoperative complications, such as new‐onset dialysis and late cardiac readmission.[6](#jah34392-bib-0006){ref-type="ref"}, [48](#jah34392-bib-0048){ref-type="ref"}, [55](#jah34392-bib-0055){ref-type="ref"}, [56](#jah34392-bib-0056){ref-type="ref"} In addition, our post hoc analysis found that women were more likely than men to have isolated CABG during an acute cardiac admission, which may, in part, explain their poorer prognosis.

Limited knowledge has been generated to date on the long‐term outcomes after combined CABG/valve surgery. We found that among those who underwent valvular surgery with concomitant CABG, women had numerically, albeit nonstatistically significantly, higher AMRs when compared with men. Sex was not a risk factor for long‐term survival after combined CABG/valve surgery. Our findings corroborate a small case series of 1567 patients who had combined CABG and aortic, mitral, or multiple‐valve surgeries in Toronto, Canada, between 1990 and 2000, in which women and men had similar rates of survival at 5.3 years of follow‐up.[40](#jah34392-bib-0040){ref-type="ref"} In a more recent cohort of 5867 patients undergoing combined CABG and aortic valve surgery (33% women), the risk of in‐hospital mortality was higher in women compared with men (odds ratio, 2.00; 95% CI, 1.44--2.79). Long‐term outcomes were not examined.[44](#jah34392-bib-0044){ref-type="ref"} These authors concluded that substantial sex differences existed in patient presentation and mortality risk factors, and that standard risk scores, such as the EuroSCORE, did not perform as well in women as in men.

The sex differences in long‐term outcomes after combined CABG/mitral valve surgery have not been systematically reported. In the current study, we found a significantly higher AMR in women undergoing CABG/mitral valve surgery. This could be attributed to the poorer prognosis after CABG in women with HF,[6](#jah34392-bib-0006){ref-type="ref"}, [7](#jah34392-bib-0007){ref-type="ref"} as those needing combined CABG/mitral valve surgery are more likely to have HF with reduced EF. The presence of HF compounds the sex‐specific challenges in patients with coronary artery disease and further places women at risk.

We found no sex differences in long‐term survival after single‐valve surgery. This finding was likely driven by a higher overall number of AVRs performed compared with mitral valve surgery. In a nationwide study of all patients undergoing MVR in the Netherlands between 2007 and 2011 (N=3411; 42% women), no sex differences were reported for mortality in the hospital.[43](#jah34392-bib-0043){ref-type="ref"} Long‐term outcomes were not evaluated in this study. In a study of 743 patients (28% women) who underwent mitral repair for degenerative mitral regurgitation between 2001 and 2014 in Ottawa, Canada,[57](#jah34392-bib-0057){ref-type="ref"} sex differences in survival were not observed at 5 years. However, the authors found that women were more likely to present with more advanced disease than men at the time of surgery. A study of 183 792 Medicare beneficiaries, between 2000 and 2009, found no difference in long‐term survival by sex after mitral valve surgery. However, the authors found that women were more likely to receive mitral replacement instead of repair, and that repair restored life expectancy for men but not for women.[18](#jah34392-bib-0018){ref-type="ref"} In a cohort of 3118 (40.4% women) who had MVR or AVR in Ottawa, Canada, between 1976 and 2006, no statistically significant sex differences were observed in survival after MVR.[58](#jah34392-bib-0058){ref-type="ref"} The same authors also found women to have a lower risk of mortality 5.6 years after bioprosthetic AVR (adjusted HR, 0.5; 95% CI, 0.3--0.6), but no difference in survival between sexes after mechanical AVR. We also found that life expectancy was higher in men than women after mitral valve repair; however, women had higher life expectancy after MVR than men. In our subgroup of patients who underwent isolated AVR, we found no sex differences in long‐term survival irrespective of the complexity of surgery. The findings of the Ottawa study[58](#jah34392-bib-0058){ref-type="ref"} pertaining to survival after bioprosthetic AVR differ from the current province‐wide study and may reflect center‐based practice and experience with selection of mechanical versus bioprosthetic valves.

Limitations {#jah34392-sec-0022}
-----------

This study has several limitations. First, the sex differences in outcomes are representative of surgical practice in Ontario. Similar research needs to be conducted in other settings to confirm the generalizability of our findings. Second, our data sources lacked details about the specific valve implant type (ie, bioprosthetic versus mechanical, and brand name) or repair technique. This precluded us from being able to examine sex‐specific differences in outcomes in detail. Third, we lacked some details about patient characteristics, such as race and ethnicity, which some studies have shown may be independent predictors of mortality after cardiac surgery.[59](#jah34392-bib-0059){ref-type="ref"} The inability to measure, and thereby adjust for, differences in such characteristics could have explained, in part, the differences in mortality observed in this study. Third, cohort studies are by nature subject to residual confounding.

Conclusions {#jah34392-sec-0023}
===========

We described the sex differences in long‐term outcomes after a variety of cardiac procedures in a large, real‐world cohort. We found a statistically significant association between female sex and long‐term mortality after cardiac surgery. Specifically, women experienced higher rates of mortality than men after CABG and combined CABG/mitral valve surgery, and mortality risk factors also differed by sex. Perioperative optimization and long‐term follow‐up should be tailored to younger women with a history of MI and previous PCI and older men with a history of COPD and depression. Given the substantial sex differences in patient presentation for coronary and valvular heart disease, further efforts need to be directed at the education of both physicians and patients in the early recognition of acute presentation of cardiac disease in women. In addition, given the poorer performance of standard risk scores in women, further research is needed to derive and validate sex‐specific risk prediction models in patients undergoing cardiac surgery.
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**Table S1.** Proportion of Patients With Surgeries Performed During an Acute, Non‐Elective Hospital Admission, Stratified by Sex and Procedure Type

**Figure S1.** Crude and age‐standardized mortality rates and adjusted hazard ratios, stratified by sex and procedure type.
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